Risk to the breast-fed neonate from codeine treatment to the mother: a quantitative mechanistic modeling study.
about
Development of Human Membrane Transporters: Drug Disposition and PharmacogeneticsPharmacogenetics and anaesthesia: the value of genetic profilingA mechanistic, model-based approach to safety assessment in clinical developmentIntegrating cellular metabolism into a multiscale whole-body modelConcomitant use of tamoxifen and endoxifen in postmenopausal early breast cancer: prediction of plasma levels by physiologically-based pharmacokinetic modeling.Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for codeine therapy in the context of cytochrome P450 2D6 (CYP2D6) genotypePharmacogenomic considerations in opioid analgesia.Clinical Pharmacogenetics Implementation Consortium guidelines for cytochrome P450 2D6 genotype and codeine therapy: 2014 update.Baby boy blue - why is this newborn lethargic?A clinical tool for reducing central nervous system depression among neonates exposed to codeine through breast milk.Prediction of a potentially effective dose in humans for BAY 60-5521, a potent inhibitor of cholesteryl ester transfer protein (CETP) by allometric species scaling and combined pharmacodynamic and physiologically-based pharmacokinetic modellingPharmacogenomic testing: relevance in medical practice: why drugs work in some patients but not in others.Medical and psychological risks and consequences of long-term opioid therapy in women.Guidelines for maternal codeine use during breastfeeding.Approaches to deorphanization of human and microbial cytochrome P450 enzymes.Pharmacogenomics and active surveillance for serious adverse drug reactions in children.Ethical considerations in CYP2D6 genotype testing for codeine-prescribed breastfeeding mothers.Adverse drug reactions in women's health care.An update on computational oral absorption simulation.Systems approaches in risk assessment.Codeine should not be prescribed for breastfeeding mothers or children under the age of 12.Pain management after cesarean: a randomized controlled trial of oxycodone versus intravenous piritramide.CYP2D6 genetic polymorphisms and their relevance for poisoning due to amfetamines, opioid analgesics and antidepressants.The pharmacogenetics of opioid therapy in the management of postpartum pain: a systematic review.Evaluation of the Safety of Drugs and Biological Products Used During Lactation: Workshop Summary.Modeling drug passage into human milk.Gestation-Specific Changes in the Anatomy and Physiology of Healthy Pregnant Women: An Extended Repository of Model Parameters for Physiologically Based Pharmacokinetic Modeling in Pregnancy.The pharmacogenetics of codeine pain relief in the postpartum period.Using Bayesian-PBPK modeling for assessment of inter-individual variability and subgroup stratification.A computational systems biology software platform for multiscale modeling and simulation: integrating whole-body physiology, disease biology, and molecular reaction networks.Towards whole-body systems physiology.First dose in children: physiological insights into pharmacokinetic scaling approaches and their implications in paediatric drug development.Is maternal opioid use hazardous to breast-fed infants?Opioids and lactation: insufficient evidence of safety.Postpartum maternal codeine therapy and the risk of adverse neonatal outcomes: a retrospective cohort study.Scientific Opinion on the risks for public health related to the presence of opium alkaloids in poppy seedsUsing Physiologically Based Pharmacokinetic Modeling for Mechanistic Insight: Cases of Reverse Translation.
P2860
Q26786582-5395A6F7-F348-4144-A792-13BD40B74296Q26859221-D82668C5-0C64-4E14-9CEC-59C2AE48C4DAQ28395802-BB7BBF12-F06D-4803-9789-17DBAE30A53FQ28484829-5E848BFE-A17E-45B8-B9ED-52B6130E3ECEQ33756964-8479AD30-8CF0-46E7-8360-10D3679E643BQ34243414-A9762D1D-BC68-40A8-BC33-553E09A24E7EQ34316700-3F2615E0-529B-42D1-9429-217489FBBC08Q34399802-67092B7E-EAE2-48E5-9046-A36290A186BCQ34437058-7EA9CFEA-1BFC-4461-80D7-F6F5D405769DQ34905699-5430B706-A03C-45B0-8EA2-10BD4BFE8122Q35718576-5F3429A4-4B7E-4613-96B0-E7447161D5D1Q35955515-E99C0A28-7445-4BB3-9FED-BD53A89548A7Q36709787-2FFE34A1-366D-4DFB-A5AE-51440E927A8FQ37419914-F7413A11-AA08-470B-A880-22F8CB616F44Q37759731-1CE94FB2-63A0-4EDA-9A24-0A11F3FEED66Q37791154-3EE9424D-79D8-460E-AF2F-D227F87CDC3BQ37809966-5A02F63C-1AD5-4674-A879-3FC18CB419CEQ37871038-3C8F26DC-76EA-4A62-B196-975AAA5A6A77Q37937047-F8C056BA-3A31-4039-9C9A-3FA37C913EC3Q38093360-10B74BD3-A83D-41F8-977F-736D725DB4A3Q38391114-108367F8-F412-40CA-87BB-9F9C8BA74983Q38471016-3BF9C593-6554-4F51-8348-0D1CB1FACAD0Q38496627-0F3D740C-F009-4A58-B345-F8F9CEE55FCEQ38664725-4957DE77-E79C-4408-834F-5317016D4EBCQ38683180-0807A45A-6AE3-4194-857C-AB911461EF61Q38802791-EF0DAB41-B614-42AA-A9E3-10687CB66CE7Q38841163-2C435204-5955-4797-BA20-42BC8CA1DDDAQ39192887-33648223-A925-45FA-9DE3-CBCC9DEA826EQ41692388-7132ECFE-BF9F-438E-8B03-6D9908E44173Q42018625-C0021B5F-B2A3-4EEC-AA3D-A3FE555AFBF8Q42397948-47850B84-2F82-4AC0-A038-3CEF99782F26Q42577721-AE836459-266B-47F4-808E-FEE6C26F6EFDQ43063862-A3FFFE73-A1ED-414B-93AC-198F49387351Q45983281-422E8241-DB64-402C-ABF7-68F67C2CF89EQ46324284-57560185-E468-42C0-BC48-32A87F9EA39FQ47150721-915235A7-E4C4-4527-8F2D-1C56C79B9FC9Q55279653-B5900B26-48FC-4547-A166-F85BF30FB36A
P2860
Risk to the breast-fed neonate from codeine treatment to the mother: a quantitative mechanistic modeling study.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Risk to the breast-fed neonate ...... ve mechanistic modeling study.
@en
Risk to the breast-fed neonate ...... ve mechanistic modeling study.
@nl
type
label
Risk to the breast-fed neonate ...... ve mechanistic modeling study.
@en
Risk to the breast-fed neonate ...... ve mechanistic modeling study.
@nl
prefLabel
Risk to the breast-fed neonate ...... ve mechanistic modeling study.
@en
Risk to the breast-fed neonate ...... ve mechanistic modeling study.
@nl
P2093
P2860
P356
P1476
Risk to the breast-fed neonate ...... ive mechanistic modeling study
@en
P2093
P2860
P304
P356
10.1038/CLPT.2009.151
P407
P50
P577
2009-08-26T00:00:00Z